WilliamDHardyMD

PubMed

• Five-year safety evaluation of maraviroc in HIV-1-infected treatment-experienced patients.
  Gulick, R. M.,Fatkenheuer, G.,Burnside, R.,Hardy, W. D.,Nelson, M. R.,Goodrich, J.,Mukwaya, G.,Portsmouth, S.,Heera, J. R.> ;J. Acquir. Immune Defic. Syndr.. 2014 Jan 15
• 52 citations
  Isolation and characterization of antimicrobial compounds in plant extracts against multidrug-resistant Acinetobacter baumannii.
  Yoko Miyasaki, John Rabenstein, Joshua Rhea, Marie Laure V Crouch, Ulla Mocek, Patricia Emmett Kittell, Margie Morgan, W. S. Nichols, M. M. Van Benschoten, W D Hardy, ...> ;Plos One. 2013 Apr 22
• 17 citations
  Drug safety evaluation of maraviroc for the treatment of HIV infection
  Jan-Christian Wasmuth, Jürgen K. Rockstroh, W D Hardy> ;Expert Opinion on Drug Safety. 2012 Jan 1
• 8 citations
  Seroprevalence of HTLV-I and HTLV-II among a cohort of HIV-infected women and women at risk for HIV infection
  Edward E. Telzak, Ronald C. Hershow, Leslie A. Kalish, William D. Hardy, Evelyn Zuckerman, Alexandra M. Levine, Robert Delapenha, Jack DeHovitz, Ruth M. Greenblatt, Ka...> ;Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 1998 Dec 15
• 7 citations
  Isolation of a new feline sarcoma virus (HZ1-FeSV): Biochemical and immunological characterization of its translation product
  Harry W. Snyder, Mitra C. Singhal, Evelyn E. Zuckerman, William D. Hardy> ;Virology. 1984 Jan 15
• 47 citations
  The Hardy–Zuckerman 2-FeSV, a new feline retrovirus with oncogene homology to Abelson-MuLV
  Peter Besmer, William D. Hardy, Evelyn E. Zuckerman, Peter J. Bergold, L. Lederman, Harry W. Snyder> ;Nature. 1983 Jun 30
• 59 citations
  Development of virus non-producer lymphosarcomas in pet cats exposed to FeLV.
  William D. Hardy, A. J. McClelland, Evelyn E. Zuckerman, Harry W. Snyder, E. G. MacEwen, D.P. Francis, Myron Essex> ;Nature. 1980 Nov 6
• 78 citations
  Characterisation of a tumour-specific antigen on the surface of feline lymphosarcoma cells.
  Harry W. Snyder, William D. Hardy, Evelyn E. Zuckerman, Erwin Fleissner> ;Nature. 1978 Oct 19
• 58 citations
  A feline leukaemia virus- and sarcoma virus-induced tumour-specific antigen
  William D. Hardy, Evelyn E. Zuckerman, E. Gregory Macewen, Audrey A. Hayes, Myron Essex> ;Nature. 1977 Nov 17
• 15 citations
  The epidemiology of the feline leukemia virus (FeLV).
  William D. Hardy, A. J. McClelland, E. Gregory Macewen, Paul W. Hess, Audrey A. Hayes, Evelyn E. Zuckerman> ;Cancer. 1977 Apr 1
• Increased pericardial fat accumulation is associated with increased intramyocardial lipid content and duration of highly active antiretroviral therapy exposure in pati...
  Diaz-Zamudio, M.,Dey, D.,LaBounty, T.,Nelson, M.,Fan, Z.,Szczepaniak, L. S.,Hsieh, B. P.,Rajani, R.,Berman, D.,Li, D.,Dharmakumar, R.,Hardy, W. D.,Conte, A. H.> ;J Cardiovasc Magn Reson. 2015 Nov 02
• Two-year safety and virologic efficacy of maraviroc in treatment-experienced patients with CCR5-tropic HIV-1 infection: 96-week combined analysis of MOTIVATE 1 and 2.
  Hardy, W. D., Gulick, R. M., Mayer, H., Fätkenheuer, G., Nelson, M., Heera, J., Rajicic, N., Goodrich, J.> ;J Acquir Immune Defic Syndr. 2010 Dec 15
• Antiretroviral therapy in coinfected patients: viral hepatitis and tuberculosis.
  Rockstroh, J. K., Hardy, W. D.> ;Curr Opin HIV AIDS. 2006 Sep 01
• Evaluation of an indirect enzyme-linked immunosorbent assay for the detection of feline lentivirus-reactive antibodies in wild felids, employing a puma lentivirus-deri...
  Van Vuuren, M., Stylianides, E., Kania, S. A., Zuckerman, E. E., Hardy, W. D.> ;Onderstepoort J Vet Res. 2003 Mar
• The feline oncornavirus-associated cell membrane antigen (FOCMA) is related to, but distinguishable from, FeLV-C gp70.
  Snyder, H. W., Singhal, M. C., Zuckerman, E. E., Jones, F. R., Hardy, W. D.> ;Virology. 1983 Dec
• Feline leukemia virus nonproducer lymphosarcomas of cats as a model for the etiology of human leukemias.
  Hardy, W. D., McClelland, A. J., Zuckerman, E. E., Snyder, H. W., MacEwen, E. G., Francis, D., Essex, M.> ;Haematol Blood Transfus. 1981
• Isolation and characterization of proteins carrying the feline oncornavirus-associated cell-membrane antigen.
  Snyder, H. W., Phillips, K. J., Hardy, W. D., Zuckerman, E. E., Essex, M., Sliski, A. H., Rhim, J.> ;Cold Spring Harb Symp Quant Biol. 1980
• Peptide T does not inhibit HIV-1 infection in an in vitro serum-free system.
  Baron, P. A., Polsky, B., Gold, J. W., Zuckerman, E. E., Hardy, W. D., Meyer-Glauner, W., Armstrong, D.> ;AIDS. 1988 Jun
• Immunological and biochemical characterization of HZ2 feline sarcoma virus and Abelson murine leukaemia virus translation products.
  Lederman, L., Singhal, M. C., Besmer, P., Zuckerman, E. E., Hardy, W. D., Snyder, H. W.> ;J Gen Virol. 1985 Sep
• A seroepidemiological survey of HTLV-I infection in Shanghai and Chongqing cities in China.
  Pan, X. Z., Qiu, Z. D., Chein, N., Gold, J. W., Hardy, W. D., Zuckerman, E., Wang, Q. N., Armstrong, D.> ;AIDS. 1991 Jun
• Ten-year study comparing enzyme-linked immunosorbent assay with the immunofluorescent antibody test for detection of feline leukemia virus infection in cats.
  Hardy, W. D., Zuckerman, E. E.> ;J Am Vet Med Assoc. 1991 Nov 15
• Development of the immunofluorescent antibody test for detection of feline leukemia virus infection in cats.
  Hardy, W. D., Zuckerman, E. E.> ;J Am Vet Med Assoc. 1991 Nov 15
• Join now to see all